Docmode Health Technologies Ltd

As of 01-October, Docmode Health Technologies Ltd is experiencing a price increase to 78.80, up 5.0%, with strong short-term performance and increased investor participation. Despite this recent rise, the stock has underperformed year-to-date, declining 10.81% compared to the Sensex's gain of 5.04%.

As of 29-Sep, Docmode Health Technologies Ltd is currently priced at 71.55, reflecting a short-term performance surge with a 1-week return of +23.47% and a 1-month return of +55.54%, despite a year-to-date decline of -19.02%. The stock's recent rise is accompanied by decreased investor participation, raising concerns about its sustainability.

As of 25-Sep, Docmode Health Technologies Ltd is trading at 64.95, reflecting a recent price increase and strong short-term performance, significantly outperforming the Sensex. Despite a year-to-date decline, the stock shows positive trends with increased investor interest and favorable moving averages.

As of 23-Sep, Docmode Health Technologies Ltd is currently priced at 59.00, reflecting a recent upward trend but a negative year-to-date performance of -33.22%. Despite strong short-term gains, declining investor participation raises concerns about the stock's ability to sustain its momentum.

As of 22-Sep, Docmode Health Technologies Ltd is currently priced at 57.95, reflecting a 4.98% increase, but has a year-to-date decline of -34.41%. Despite recent strong short-term performance, investor participation has decreased, suggesting that the current gains may not indicate a sustained recovery.

As of 19-Sep, Docmode Health Technologies Ltd is experiencing a price increase to 55.20, up 9.96%, and has significantly outperformed its sector today. Despite a strong short-term return of +34.63% over the past week, the stock has a year-to-date decline of 37.52%.

As of 18-Sep, Docmode Health Technologies Ltd is currently priced at 50.20, reflecting a 9.97% increase today and a 22.44% gain over the past week, although it has declined 43.18% year-to-date. The stock's delivery volume has surged by 92.31%, indicating increased investor interest despite its longer-term underperformance compared to the Sensex.

As of 17-Sep, Docmode Health Technologies Ltd is currently priced at 45.65, reflecting a 10.0% increase today, but has seen a significant year-to-date decline of 48.33%. While it has outperformed the Sensex in the short term, its long-term performance remains concerning.

As of 16-Sep, Docmode Health Technologies Ltd's stock price is 41.50, up 1.22%, with a significant increase in delivery volume. However, it has underperformed over the past month and year, with declines of 19.57% and 53.03%, respectively, indicating ongoing challenges despite today's positive movement.

As of 15-Sep, Docmode Health Technologies Ltd is priced at 41.00, unchanged, but has declined 20.54% over the past month and 53.59% year-to-date, underperforming the market. Despite a recent increase in investor participation, the stock remains below key moving averages, indicating a bearish trend.

As of 12-Sep, Docmode Health Technologies Ltd is priced at Rs. 41.00, showing no change and a 52-week low of Rs. 36.9, with a year-to-date decline of 53.59%. Despite a recent increase in investor participation, the stock's performance remains significantly weaker than the broader market, which has seen gains.

As of 11-Sep, Docmode Health Technologies Ltd is priced at 41.00, showing no change and a 0.00% movement. The stock has declined by 53.59% year-to-date and is underperforming compared to the benchmark Sensex, despite a 150% increase in delivery volume indicating rising investor interest.

As of 10-Sep, Docmode Health Technologies Ltd is priced at 41.00 with no change, indicating a downward trend as it trades below all key moving averages and has seen a 20.54% decline over the past month. The stock's performance is significantly lagging behind the benchmark Sensex, which has increased during the same period.

As of 09-Sep, Docmode Health Technologies Ltd is priced at 41.00 with no change, reflecting a 0.00% movement. The stock has significantly underperformed, with declines of 4.76% over the past week, 20.54% over the past month, and 53.59% year-to-date, indicating a bearish trend and weak investor sentiment.

As of 08-Sep, Docmode Health Technologies Ltd is priced at 41.00 with no change in price. The stock has significantly underperformed, with declines over various periods and low investor participation, indicating a lack of confidence compared to the benchmark Sensex.

As of 05-Sep, Docmode Health Technologies Ltd is priced at 41.00 with no change, reflecting a downward trend as it trades below all key moving averages. The stock has seen significant declines, with a year-to-date return of -53.59%, contrasting sharply with the Sensex's positive return of 4.64%.

As of 04-Sep, Docmode Health Technologies Ltd is priced at 41.00, with a year-to-date decline of 53.59% and a one-year drop of 67.84%. The stock is underperforming compared to the broader market, indicated by its significant losses and reduced investor interest.

As of 03-Sep, Docmode Health Technologies Ltd's stock price is at 41.00, down 4.76%, and has significantly underperformed its sector and the broader market, with a year-to-date decline of 53.59%. Despite increased investor participation, the stock continues to struggle against negative performance metrics.

As of 02-Sep, Docmode Health Technologies Ltd is priced at 43.05 with no change, reflecting a 0.00% movement. The stock has significantly underperformed, with declines of 6.41% over the past week and 51.27% year-to-date, indicating a bearish trend despite a slight outperformance against its sector today.